Abstract
The ability of a modified live canine parvovirus type 2b vaccine to elicit active immunization in pups with maternally derived antibodies (MDA) by intranasal administration was evaluated. The vaccine induced seroconversion in 100% of pups with MDA titers of < or = 80 and in 51.6% of pups with titers between 160 and 320.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Intranasal
-
Animals
-
Antibodies, Viral / therapeutic use*
-
Dogs
-
Immunization
-
Parvoviridae Infections / prevention & control
-
Parvoviridae Infections / veterinary
-
Parvovirus, Canine / immunology*
-
Viral Vaccines*
Substances
-
Antibodies, Viral
-
Viral Vaccines